Navigation Links
Amicus Therapeutics Announces Change to Board of Directors
Date:2/18/2009

CRANBURY, N.J., Feb. 18 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD) announced today that Stephen Bloch, M.D., General Partner with Canaan Equity Partners, has resigned from the Company's Board of Directors effective February 17, 2009. Dr. Bloch served as a member of Amicus' board since 2004.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has completed Phase 2 clinical trials of Amigal for the treatment of Fabry disease and is conducting Phase 2 clinical trials of Plicera for the treatment of Gaucher disease and AT2220 for the treatment of Pompe disease.

FOLD-G


'/>"/>
SOURCE Amicus Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Amicus Therapeutics Announces Fourth Quarter and Full Year 2008 Financial Results
2. Amicus Therapeutics Announces Fourth Quarter and Year End 2008 Financial Results Release Date
3. Amicus Therapeutics Adds Sol J. Barer, Ph.D. to Board of Directors
4. Amicus Therapeutics to Present at Lazard Capital Markets Healthcare Conference
5. Amicus Therapeutics Announces Third Quarter 2008 Financial Results
6. Amicus Therapeutics Announces Third Quarter 2008 Results Release Date
7. Amicus Therapeutics to Present at the 2008 UBS Global Life Sciences Conference
8. Amicus Therapeutics Opens Research Facility in San Diego
9. Amicus Therapeutics to Present at the 2008 BioCentury NewsMakers in the Biotech Industry Conference
10. Amicus Therapeutics Announces Second Quarter 2008 Results Release Date
11. Amicus Therapeutics Announces First Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/18/2014)... 2014 The Asia-Pacific Bio-based Advanced ... the bio-based advanced phase change material market in ... Browse through the TOC of the Asia-Pacific Bio-based ... an idea of the in-depth analysis provided. This ... the Asia-Pacific bio-based advanced phase change material market, ...
(Date:10/18/2014)... 2014 The Asia-Pacific hardware encryption display ... Asia-Pacific with analysis and forecast of revenue. This market ... to reach $51,362.6 million by 2018, at a CAGR ... the TOC of the Asia-Pacific hardware encryption market report, ... This also provides a glimpse of the segmentation of ...
(Date:10/18/2014)... New York, NY (PRWEB) October 18, 2014 ... at a healthy rate in the five years to ... by several federal renewable energy tax credits that encouraged ... states have enacted renewable portfolio standards (RPSs), which require ... a percentage of their total energy portfolio. Increased campaigning ...
(Date:10/18/2014)... 2014 The “Global Diagnostic Electrocardiograph ... by End-user (Hospitals, Home/Ambulatory, Research Center, Physician Office, ... -Global Forecast to 2020” provides a detailed overview ... market trends, and strategies impacting the global diagnostic ... of the revenue and share analysis. , The ...
Breaking Biology Technology:The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 3The Asia-Pacific Bio-based Advanced Phase Change Materials Market is estimated to grow to $39.8 million by 2018 - New Report by MicroMarket Monitor 4The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 2The Asia-Pacific hardware encryption display market is expected to reach $51,362.6 million by 2018 - New Report by MicroMarket Monitor 3Biomass Power in the US Industry Market Research Report from IBISWorld Has Been Updated 2Biomass Power in the US Industry Market Research Report from IBISWorld Has Been Updated 3The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 2The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 3The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 4The Electrocardiograph (ECG) Market Is Expected to Reach $5,435 Million By 2020 - New Research Report by MarketsandMarkets 5
... Coming out of the Tour de France s fourth stage ... in the lead. That must make the designers at Trek ... , ,Founded in 1976 in Waterloo, Wisconsin, the now-international company has ... now hoping its latest designs will help lead to a sixth ...
... Inacom Information Systems announced last week it has ... certification represents the highest level of partnership and, according ... expertise in three specializations in addition to achieving a ... in IP Telephony, VPN Security and wireless LAN. ...
... ,Are your projects still late? Do they continue to cost ... answer is probably yes. , ,The point of this series ... about it you learn new things every day. You continuously ... to class. Youve learned the latest techniques. The same is ...
Cached Biology Technology:Armstrongs new Trek modeled on AMD 64-bit processors 2Inacom Information Systems achieves Cisco Systems Partner -Gold Certified status 2Project Performance: Is your project late? Over budget? 2Project Performance: Is your project late? Over budget? 3
(Date:10/15/2014)... Fred Alt will be awarded the 44th Rosenstiel Award ... for his pioneering research exploring the mechanisms of genomic ... cancer cells. Alt is the second alumnus to win ... Nobel Prize in 2003. , Alt is the Charles ... at Harvard Medical School and an investigator at the ...
(Date:10/14/2014)... house fly genome for the first time, revealing robust ... that thrives in pathogen-rich dung piles and garbage heaps. ... Genome Biology , will increase understanding of house ... adapt to resist insecticides, which could lead to novel ... and transmit more than 100 human and animal diseases, ...
(Date:10/14/2014)... scientists led by researchers at the University of ... Miami Miller School of Medicine (UMMSM) have identified ... bipolar (manic depressive) disorder, a breakthrough that could ... disorder, as well as depression and other related ... this week in Nature Molecular Psychiatry , ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2House fly genome reveals expanded immune system 2Rare genetic disease protects against bipolar disorder 2Rare genetic disease protects against bipolar disorder 3
... complete sequencing of a brown algal genome, an international ... the evolution of two key prerequisites for higher life ... renowned science magazine Nature reported in its ... five-year research project, successfully decoded all hereditary information ...
... factors controlling when and in what tissues genes are expressed ... normally found in fetal kidneys. These findings by Massachusetts ... pathways that are critical for Wilms tumor development and may ... in the June 4 Cell Stem Cell . ...
... University study found that strengthening inspiratory muscles by performing ... amount of oxygen these same breathing muscles required during ... Louise Turner, a researcher in the Department of ... endurance activity, such as running, swimming or cycling performed ...
Cached Biology News:How did higher life evolve? 2How did higher life evolve? 3Study finds epigenetic similarities between Wilms tumor cells and normal kidney stem cells 2Inspiratory muscle training and endurance sport performance 2
2ndGen Predilute antibody for staining tissue sections. Optimized for use with Zymeds Histostain-PLUS, NBA, HistoST5050, and Cap-Plus IHC Kits.Labeling: ASR...
Sprague Dawley rats, 7-8 weeks of age, mixed gender; collected by exsanguination in Alsever's solution at 1:2 dilution...
... The S.c. EasyComp Transformation Kit ... transformation-competent Saccharomyces cerevisiae cells. Advantages over ... spheroplast formation or LiCl methods include:- Cells ... than 30 minutes - Competent cell preparation ...
Trop-2 Purified Anti-Human clone 162-46, Isotype Mouse IgG 1 , 100 µg Consult technical datasheet for details....
Biology Products: